The overexpression of METTL1 increases chemosensitivity of CC cells to cisplatin, because within the carcinoma treating process, the chemoresistance regulating process was crucially affected by METTL1-mediated m7G (Liu et al., 2019). This evidence concerns the gene METTL1 and carcinoma.